[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA9811348B - Statin-carboxyalkylether combinations - Google Patents

Statin-carboxyalkylether combinations

Info

Publication number
ZA9811348B
ZA9811348B ZA9811348A ZA9811348A ZA9811348B ZA 9811348 B ZA9811348 B ZA 9811348B ZA 9811348 A ZA9811348 A ZA 9811348A ZA 9811348 A ZA9811348 A ZA 9811348A ZA 9811348 B ZA9811348 B ZA 9811348B
Authority
ZA
South Africa
Prior art keywords
carboxyalkylether
statin
combinations
carboxyalkylether combinations
Prior art date
Application number
ZA9811348A
Other languages
English (en)
Inventor
Charles Larry Bisgaier
Roger Schofield Newton
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA9811348B publication Critical patent/ZA9811348B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9811348A 1997-12-12 1998-12-10 Statin-carboxyalkylether combinations ZA9811348B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
ZA9811348B true ZA9811348B (en) 1999-06-14

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811348A ZA9811348B (en) 1997-12-12 1998-12-10 Statin-carboxyalkylether combinations

Country Status (30)

Country Link
EP (1) EP1045691B1 (is)
JP (1) JP2002508320A (is)
KR (1) KR20010033003A (is)
AR (1) AR017851A1 (is)
AT (1) ATE285762T1 (is)
AU (1) AU754089B2 (is)
BR (1) BR9813542A (is)
CA (1) CA2304612A1 (is)
CO (1) CO4970816A1 (is)
CR (1) CR5926A (is)
CU (1) CU20000140A7 (is)
DE (1) DE69828442T2 (is)
DK (1) DK1045691T3 (is)
ES (1) ES2230733T3 (is)
GT (1) GT199800196A (is)
HN (1) HN1998000185A (is)
HU (1) HUP0004547A3 (is)
IL (1) IL135349A0 (is)
IS (1) IS2150B (is)
MY (1) MY118381A (is)
NO (1) NO20002966L (is)
NZ (1) NZ503982A (is)
PA (1) PA8464601A1 (is)
PE (1) PE20000017A1 (is)
PL (1) PL341066A1 (is)
PT (1) PT1045691E (is)
SV (1) SV1998000146A (is)
UY (1) UY25299A1 (is)
WO (1) WO1999030704A1 (is)
ZA (1) ZA9811348B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010033017A (ko) * 1997-12-12 2001-04-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 과지질혈증 치료제인 스타틴-ＬＰ(ａ) 억제제의 병용 제제
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
EE200100199A (et) * 1998-09-30 2002-06-17 Warner-Lambert Company Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (is) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
JP4750995B2 (ja) 2000-01-25 2011-08-17 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー カルシウムジカルボキシレートエーテル、その製造法、及びそれを用いた血管系疾患及び糖尿病の治療
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
CN1426299A (zh) * 2000-04-26 2003-06-25 沃尼尔·朗伯公司 抗高血压剂和用途
US6689807B1 (en) 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
US6777552B2 (en) 2001-08-16 2004-08-17 Teva Pharmaceutical Industries, Ltd. Processes for preparing calcium salt forms of statins
HUP0500616A3 (en) * 2001-08-16 2011-07-28 Teva Pharma Processes for preparing calcium salt forms of statins
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
WO2013103842A1 (en) * 2012-01-06 2013-07-11 Michigan Life Therapeutics, Llc Methods of reducing risk of cardiovascular disease
MX2018005540A (es) * 2015-11-06 2018-11-09 Gemphire Therapeutics Inc Tratamiento de dislipemia mixta.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
UY25299A1 (es) 2001-08-27
HUP0004547A3 (en) 2001-12-28
IL135349A0 (en) 2001-05-20
NZ503982A (en) 2002-03-28
ATE285762T1 (de) 2005-01-15
CO4970816A1 (es) 2000-11-07
EP1045691B1 (en) 2004-12-29
WO1999030704A1 (en) 1999-06-24
DE69828442D1 (de) 2005-02-03
DK1045691T3 (da) 2005-03-14
SV1998000146A (es) 1999-09-30
HN1998000185A (es) 1999-06-02
EP1045691A1 (en) 2000-10-25
PE20000017A1 (es) 2000-01-20
PT1045691E (pt) 2005-03-31
GT199800196A (es) 2000-06-03
CR5926A (es) 2000-03-06
CA2304612A1 (en) 1999-06-24
NO20002966D0 (no) 2000-06-09
CU20000140A7 (es) 2005-10-19
IS2150B (is) 2006-10-13
MY118381A (en) 2004-10-30
BR9813542A (pt) 2000-10-10
AR017851A1 (es) 2001-10-24
JP2002508320A (ja) 2002-03-19
PL341066A1 (en) 2001-03-26
DE69828442T2 (de) 2005-06-02
PA8464601A1 (es) 2001-12-14
KR20010033003A (ko) 2001-04-25
ES2230733T3 (es) 2005-05-01
AU1591599A (en) 1999-07-05
IS5445A (is) 2000-04-14
HUP0004547A2 (hu) 2001-05-28
NO20002966L (no) 2000-06-09
AU754089B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
ZA9811348B (en) Statin-carboxyalkylether combinations
HU9700316V0 (en) Block-book
PL338125A1 (en) Cartridge-projectile
DE69814118D1 (en) Anti-first-pass-effect-substanzen
GB9718051D0 (en) Rail-cam
GB2324019B (en) Lawn-Trimmer
GB9724366D0 (en) Selectaspeed
GB9711565D0 (en) Cafetiere
GB9820170D0 (en) AppliquÚs
CA81694S (en) Tape-rule
SI1045691T1 (en) Statin-carboxyalkylether combinations
AU132187S (en) Gamesboard
GB9727328D0 (en) Dunkies
GB9707202D0 (en) Hypocage
GB9709665D0 (en) Sunlounger
GB9706104D0 (en) Digmate
GB9711754D0 (en) Cross-net
GB9711886D0 (en) Stairlifts
GB9715254D0 (en) Pjer-dent-set
GB9716609D0 (en) Strawcrete
GB9716613D0 (en) Dripstick
GB9702975D0 (en) Toolmate
GB9702947D0 (en) Sweta
GB9720447D0 (en) Euromote
GB9720647D0 (en) Supertext